Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
VHA Deploys Agentic AI Operating System to Improve Care Delivery
The new agentic AI system connects teams, automates workflows and accelerates decision-making across VA medical centers.
4m read -
NNSA Eyes Human-Machine Teaming to Boost Mission Efficiency
Officials say AI will reshape roles, enhance cybersecurity and support predictive maintenance as NNSA modernizes operations.
2m read -
White House Sets Sights on National AI Legislation by 2027
OSTP Director Michael Kratsios said the new AI framework sets stage for federal legislation and warned against fragmented state regulations.
2m read -
NASA Expands Nuclear, Workforce Strategies to Power Future Missions
NASA is advancing nuclear systems and workforce models to accelerate space exploration and mission readiness.
2m read
